Clin2
NCT07082231Possibly a fitNot yet recruiting

Colitis and polyp patient biobank study at Bordeaux Hospital

Ulcerative ColitisInflammatory Bowel Disease (IBD)Acute Severe Ulcerative Colitis

Treatments studied

Part of Digestive system clinical trials.

This study collects tissue and blood samples from people with ulcerative colitis or certain colon polyps to help researchers better understand these conditions. If you are having a colonoscopy or surgery for these conditions, you may be able to participate.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older.
  • You have ulcerative colitis (diagnosed by standard guidelines) or you have colon polyps (hyperplastic polyps, sessile serrated lesions, or adenomas larger than 2 cm) that were or will be removed during a colonoscopy.
  • You speak French and have social security coverage.
  • You are not pregnant or breastfeeding.
  • You are not under legal guardianship or unable to give consent.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06502873Recruiting
Study of colon samples in IBD and healthy people

This study is gathering information from people with active Crohn's disease or ulcerative colitis, and from people without IBD. Researchers will look at samples from the colon to learn more about these conditions.

Liège
NCT05704413Recruiting
Biobank study using gut tissue in bowel disease

This study collects and stores digestive (bowel) tissue to better understand how gut bacteria may affect diseases like ulcerative colitis or Crohn’s disease. It may help researchers find future ways to improve care for people with these conditions.

Paris
NCT03809728Recruiting
Finding blood tests linked to outcomes in Crohn’s and colitis

This study looks for “biomarkers” (lab markers, like substances in blood or tissue) that may predict how Crohn’s disease or ulcerative colitis will go and how patients may respond. It may help doctors choose better monitoring or treatments in the future.

Vandœuvre-lès-Nancy
NCT05456893Recruiting
Testing blood and stool markers in active ulcerative colitis treatments

This study checks biomarkers (signals in blood and/or stool) in adults with moderate-to-severe ulcerative colitis. It compares patients starting targeted medicines and looks for marker patterns that may reflect how the disease is behaving.

Nancy, Lorraine
NCT00001184Recruiting
Studying the immune system in Crohn's and colitis

This study collects blood and tissue samples to better understand how the immune system behaves in people with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It aims to advance research rather than test a specific new treatment, and it also enrolls healthy volunteers for comparison.

Bethesda, Maryland
NCT04617184Recruiting
Join an inflammatory bowel disease registry and sample bank

This study asks people with known or suspected inflammatory bowel disease to enroll in a registry and biorepository. It helps researchers better understand the condition using health information and stored biological samples.

Austin, Texas

Hear when a new Ulcerative Colitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.